Free Trial

Amarin (AMRN) Short Interest Ratio & Short Volume

Amarin logo
$0.56 +0.00 (+0.72%)
As of 01/17/2025 04:00 PM Eastern

Amarin Short Interest Data

Amarin (AMRN) has a short interest of 18.72 million shares. This marks a 2.91% increase in short interest from the previous month. The short interest ratio (days to cover) is 13.0, indicating that it would take 13.0 days of the average trading volume of 1.17 million shares to cover all short positions.

Current Short Interest
18,720,000 shares
Previous Short Interest
18,190,000 shares
Change Vs. Previous Month
+2.91%
Dollar Volume Sold Short
$9.08 million
Short Interest Ratio
13.0 Days to Cover
Last Record Date
December 31, 2024
Outstanding Shares
410,672,000 shares
Percentage of Shares Shorted
4.56%
Today's Trading Volume
638,450 shares
Average Trading Volume
1,174,647 shares
Today's Volume Vs. Average
54%
Short Selling Amarin?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Amarin and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

AMRN Short Interest Over Time

AMRN Days to Cover Over Time

AMRN Percentage of Float Shorted Over Time

Amarin Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
12/31/202418,720,000 shares $9.08 million +2.9%N/A13 $0.49
12/15/202418,190,000 shares $8.28 million +1.3%N/A14.2 $0.46
11/30/202417,950,000 shares $9.15 million +0.1%N/A16.8 $0.51
11/15/202417,930,000 shares $8.97 million -0.1%N/A18.6 $0.50
10/31/202417,950,000 shares $10.41 million -0.7%N/A21.4 $0.58
10/15/202418,080,000 shares $10.41 million +1.2%N/A16.6 $0.58
9/30/202417,870,000 shares $11.20 million -2.0%N/A15.3 $0.63
9/15/202418,230,000 shares $10.94 million +1.4%N/A14.6 $0.60
8/31/202417,980,000 shares $11.25 million -3.4%N/A12.1 $0.63
8/15/202418,610,000 shares $11.52 million +0.8%N/A10.7 $0.62
7/31/202418,470,000 shares $12.60 million -2.4%N/A10.8 $0.68
7/15/202418,930,000 shares $14.22 million -7.3%N/A13.1 $0.75
6/30/202420,430,000 shares $14.06 million +7.4%N/A14.4 $0.69
6/15/202419,020,000 shares $14.80 million +20.3%N/A12.8 $0.78
5/31/202415,810,000 shares $13.68 million -1.6%N/A10.8 $0.87
5/15/202416,060,000 shares $15.03 million -0.7%N/A11 $0.94
4/30/202416,180,000 shares $14.90 million +2.2%N/A10.6 $0.92
4/15/202415,840,000 shares $14.55 million -12.1%N/A9.4 $0.92
3/31/202418,020,000 shares $16.05 million -0.9%N/A8.2 $0.89
3/15/202418,190,000 shares $15.62 million +7.1%N/A7.9 $0.86
2/29/202416,990,000 shares $18.18 million +1.4%N/A6.7 $1.07
2/15/202416,750,000 shares $20.44 million +16.3%N/A7.3 $1.22
1/31/202414,400,000 shares $16.27 million +12.5%N/A6.3 $1.13
1/15/202412,800,000 shares $15.10 million -6.0%N/A5.6 $1.18
12/31/202313,620,000 shares $11.85 million -8.3%N/A6.2 $0.87
12/15/202314,860,000 shares $12.33 million +0.6%N/A8 $0.83
11/30/202314,770,000 shares $11.55 million -3.6%N/A8.8 $0.78
11/15/202315,320,000 shares $11.49 million -3.6%N/A9.8 $0.75
10/31/202315,890,000 shares $11.06 million -1.7%N/A8.5 $0.70
10/15/202316,160,000 shares $12.27 million +1.8%N/A8.5 $0.76
9/30/202315,870,000 shares $14.60 million -5.4%N/A6.7 $0.92
9/15/202316,780,000 shares $16.95 million +1.7%N/A7 $1.01
8/31/202316,500,000 shares $17.33 million -9.5%N/A6.7 $1.05
8/15/202318,240,000 shares $19.15 million -9.4%N/A7.2 $1.05
7/31/202320,130,000 shares $24.16 million -0.5%N/A8.3 $1.20
7/15/202320,240,000 shares $25.10 million -2.5%N/A8 $1.24
6/30/202320,760,000 shares $24.70 million +4.4%N/A10 $1.19
6/15/202319,880,000 shares $23.66 million -3.0%N/A8.6 $1.19
5/31/202320,500,000 shares $23.99 million -2.3%N/A7.7 $1.17
5/15/202320,980,000 shares $27.27 million -12.8%N/A6.6 $1.30
4/30/202324,070,000 shares $32.49 million +0.9%N/A6.9 $1.35
4/15/202323,860,000 shares $32.21 million +7.4%N/A5.9 $1.35
3/31/202322,220,000 shares $33.33 million +17.6%N/A4.9 $1.50
3/15/202318,890,000 shares $28.71 million +30.1%N/A4.1 $1.52
2/28/202314,520,000 shares $29.48 million +20.3%N/A3.1 $2.03
2/15/202312,070,000 shares $22.93 million -4.4%N/A2.8 $1.90
1/31/202312,620,000 shares $23.47 million -14.4%N/A2.8 $1.86
1/15/202314,740,000 shares $30.81 million +11.4%N/A3.9 $2.09
12/30/202213,230,000 shares $16.01 million +37.1%N/A4.2 $1.21
12/15/20229,650,000 shares $11.87 million -0.3%N/A3.3 $1.23
11/30/20229,680,000 shares $11.13 million +1.3%N/A3.4 $1.15
11/15/20229,560,000 shares $12.24 million -5.6%N/A3.2 $1.28
10/31/202210,130,000 shares $12.46 million +5.6%N/A3.3 $1.23
10/15/20229,590,000 shares $11.03 million +8.6%N/A3.1 $1.15
9/30/20228,830,000 shares $9.62 million -7.6%N/A2.7 $1.09
9/15/20229,560,000 shares $11.85 million -24.8%N/A2.7 $1.24
8/31/202212,720,000 shares $15.01 million -9.0%N/A3.4 $1.18
8/15/202213,980,000 shares $23.35 million -41.1%N/A3.8 $1.67
7/31/202223,740,000 shares $31.57 million -10.0%N/A5.7 $1.33
7/15/202226,390,000 shares $35.63 million +12.5%N/A5.3 $1.35
6/30/202223,460,000 shares $34.96 million +4.0%N/A5 $1.49
6/15/202222,550,000 shares $40.82 million +17.1%N/A5.1 $1.81
5/31/202219,250,000 shares $27.91 million +7.9%N/A4.5 $1.45
5/15/202217,840,000 shares $26.58 million -1.4%N/A4.6 $1.49
4/30/202218,090,000 shares $48.66 million +8.3%N/A5.1 $2.69
4/15/202216,700,000 shares $54.61 million +1.3%N/A5.1 $3.27
3/31/202216,490,000 shares $54.25 million -8.0%N/A4.7 $3.29
3/15/202217,920,000 shares $51.43 million +3.8%N/A4.9 $2.87
2/28/202217,260,000 shares $57.13 million +2.6%N/A4.5 $3.31
2/15/202216,830,000 shares $60.25 million +10.6%4.3%4.2 $3.58
1/31/202215,220,000 shares $55.10 million +1.5%3.9%3.4 $3.62
1/15/202215,000,000 shares $52.80 million +5.0%3.8%3.6 $3.52
12/31/202114,290,000 shares $48.16 million -19.3%3.6%3.9 $3.37
12/15/202117,710,000 shares $57.38 million +13.3%4.5%5 $3.24
11/30/202115,630,000 shares $56.27 million -2.2%4.0%4.7 $3.60
11/15/202115,980,000 shares $63.60 million -9.7%4.1%5 $3.98
10/29/202117,700,000 shares $84.43 million -3.2%4.5%5.4 $4.77
10/15/202118,280,000 shares $94.32 million +5.8%4.7%5.5 $5.16
9/30/202117,280,000 shares $88.13 million +1.4%4.4%5.1 $5.10
9/15/202117,050,000 shares $87.98 million +3.7%4.4%4.8 $5.16
8/31/202116,450,000 shares $89.49 million +27.1%4.2%4.4 $5.44
8/13/202112,940,000 shares $70.13 million -5.4%3.3%3.5 $5.42
7/30/202113,680,000 shares $56.64 million -31.7%3.5%4 $4.14
7/15/202120,040,000 shares $82.16 million -14.9%5.1%5.6 $4.10
6/30/202123,540,000 shares $103.11 million -6.1%6.0%5.6 $4.38
6/15/202125,080,000 shares $123.39 million +5.0%6.4%5.8 $4.92
5/28/202123,890,000 shares $108.46 million -2.5%6.1%5.5 $4.54
5/14/202124,490,000 shares $104.33 million -6.0%N/A4.6 $4.26
4/30/202126,040,000 shares $136.45 million +0.2%N/A4.6 $5.24
4/15/202126,000,000 shares $132.86 million +16.6%N/A3.9 $5.11
3/31/202122,290,000 shares $141.99 million +1.4%N/A3.4 $6.37
3/15/202121,980,000 shares $142.87 million +10.3%N/A3 $6.50
2/26/202119,930,000 shares $138.51 million -1.0%N/A2.5 $6.95
2/12/202120,140,000 shares $154.88 million -0.4%N/A2.5 $7.69
1/29/202120,210,000 shares $147.53 million -8.1%N/A2.4 $7.30
1/15/202121,990,000 shares $134.80 million -0.3%N/A2.9 $6.13
12/31/202022,060,000 shares $115.37 million -9.7%N/A3.1 $5.23
12/15/202024,420,000 shares $124.30 million +3.0%N/A3.4 $5.09
11/30/202023,710,000 shares $109.07 million -6.3%N/A3.2 $4.60
11/15/202025,310,000 shares $108.33 million +6.4%N/A2.7 $4.28
10/30/202023,780,000 shares $117.00 million -3.4%N/A2.9 $4.92
10/15/202024,610,000 shares $121.82 million -1.0%N/A2.8 $4.95
9/30/202024,860,000 shares $104.66 million -8.6%N/A2.8 $4.21
9/15/202027,200,000 shares $113.70 million +3.0%N/A3.3 $4.18
8/31/202026,410,000 shares $204.94 million -5.0%N/A3.4 $7.76
8/14/202027,810,000 shares $190.78 million -8.7%N/A4.9 $6.86
7/31/202030,450,000 shares $197.32 million -0.7%N/A4.7 $6.48
7/15/202030,670,000 shares $210.40 million -5.1%N/A4.2 $6.86
6/30/202032,310,000 shares $217.12 million -2.3%N/A3.5 $6.72
6/15/202033,080,000 shares $226.60 million -3.1%N/A2.2 $6.85
5/29/202034,120,000 shares $234.06 million -5.7%9.7%2.2 $6.86
5/15/202036,180,000 shares $279.67 million -5.1%N/A2.3 $7.73
4/30/202038,130,000 shares $290.17 million -3.3%N/A2.5 $7.61
4/15/202039,440,000 shares $249.26 million +13.5%N/A2.7 $6.32
3/31/202034,750,000 shares $261.67 million -18.0%N/A2.5 $7.53
3/13/202042,375,800 shares $256.37 million -3.8%N/A5.6 $6.05
2/28/202044,040,000 shares $464.62 million +15.4%N/A5.2 $10.55
2/14/202038,180,000 shares $540.63 million -7.4%10.8%4.6 $14.16
1/31/202041,220,000 shares $670.65 million -10.5%11.7%3.9 $16.27

AMRN Short Interest - Frequently Asked Questions

What is Amarin's current short interest?

Short interest is the volume of Amarin shares that have been sold short but have not yet been covered or closed out. As of December 31st, traders have sold 18,720,000 shares of AMRN short. Learn More on Amarin's current short interest.

What is a good short interest ratio for Amarin?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AMRN shares currently have a short interest ratio of 13.0. Learn More on Amarin's short interest ratio.

Is Amarin's short interest increasing or decreasing?

Amarin saw a increase in short interest during the month of December. As of December 31st, there was short interest totaling 18,720,000 shares, an increase of 2.9% from the previous total of 18,190,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Amarin's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Amarin: ArriVent BioPharma, Inc. (19.54%), Cogent Biosciences, Inc. (7.22%), Phibro Animal Health Co. (3.79%), Avid Bioservices, Inc. (17.51%), Relay Therapeutics, Inc. (8.93%), Sana Biotechnology, Inc. (30.31%), Avadel Pharmaceuticals plc (12.21%), Tyra Biosciences, Inc. (8.27%), Cronos Group Inc. (1.64%), Immatics (8.02%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks.

What does it mean to sell short Amarin stock?

Short selling AMRN is an investing strategy that aims to generate trading profit from Amarin as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Amarin?

A short squeeze for Amarin occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AMRN, which in turn drives the price of the stock up even further.

How often is Amarin's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AMRN, twice per month. The most recent reporting period available is December, 31 2024.




This page (NASDAQ:AMRN) was last updated on 1/18/2025 by MarketBeat.com Staff
From Our Partners